Nektar Therapeutics (NKTR) Reports In-Line Q2 EPS
Go back to Nektar Therapeutics (NKTR) Reports In-Line Q2 EPS| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 75.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $75.50 | 52 Week High | $19.98 | |||
| Open | $75.50 | 52 Week Low | $10.52 | |||
| Day High | $75.50 | P/E | N/A | |||
| Day Low | $75.50 | EPS | $-1.45 | |||
| Volume | 111 | |||||

